Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue

B B Böhm1, T Aigner, C P Blobel

  • 1University of Erlangen-Nuremberg, Erlangen, Germany.

Arthritis and Rheumatism
|October 11, 2001
PubMed
Abstract

Insights

Disintegrin metalloproteinase MDC15 (ADAM15) is highly expressed in rheumatoid arthritis (RA) and osteoarthritis (OA) synovial tissue, particularly in macrophages, fibroblasts, and plasma cells. This suggests a role for MDC15 in inflammatory joint disease pathogenesis.

Area of Science:

  • Rheumatology
  • Cell Biology
  • Molecular Biology

Background:

  • Osteoarthritis (OA) and rheumatoid arthritis (RA) are inflammatory joint diseases characterized by synovial tissue changes.
  • Disintegrin metalloproteinases, including MDC15 (ADAM15), are implicated in tissue remodeling and inflammation.

Purpose of the Study:

  • To investigate the expression of MDC15 (metargidin, ADAM15) at mRNA and protein levels in synovial tissue from OA and RA patients compared to normal controls.

Main Methods:

  • Immunohistochemistry and confocal microscopy were used to analyze MDC15 protein expression.
  • In situ hybridization and RT-PCR were employed for mRNA expression analysis.
  • Synovial tissue samples from normal, OA, and RA patients were examined.

Main Results:

  • MDC15 expression was low in normal synovium, increased in OA, and highest in RA lining layers.
  • MDC15 was expressed in macrophage-like (CD68+) and fibroblast-like (CD68-) synoviocytes.
  • Strong MDC15 expression was observed in plasma cells (CD138+) in RA and OA tissues with infiltrates.
  • MDC15 was not detected in CD20+ B cells or CD4+/CD8+ T cells.

Conclusions:

  • MDC15 is highly expressed in synoviocytes and plasma cells, with prominent expression in RA synovial tissue.
  • These findings suggest a potential role for MDC15 in the pathogenesis of cartilage destruction in inflammatory joint diseases.

Related Concept Videos